MMP9 and neoplasm: Multiple tumour types have been shown to be markedly hypoxic [16], which may favour a pro-tumorigenic neutrophil phenotype—the increased release of neutrophil MMP-9 can promote cancer growth by enabling angiogenesis [144], whilst neutrophil proteases can facilitate tumour cell invasion by activating pro-MMP-2 [145].